Regeneron and Sanofi Look for Billions From COPD Drug
The companies said Dupixent showed positive results in a late-stage study of current or former smokers with the killer disease.
The companies said Dupixent showed positive results in a late-stage study of current or former smokers with the killer disease.
A number of thematic funds are focused on companies that help seniors who want to stay in their homes as ...